Please login to the form below
Vaxigrip
This page shows the latest Vaxigrip news and features for those working in and with pharma, biotech and healthcare.
AZ wins EU approval for four-strain flu vaccine
Sanofi is still to have its four-strain vaccine recommended in the EU, however, although it was accepted for review by the EMA under the brand name Vaxigrip in April. ... The vaccine is also approved for the youngest patient population in Europe, as
Latest news
-
Sanofi’s four-strain flu vaccine Vaxigrip under review in EU
Pharma company also launches production of ingredient for malaria drug. Sanofi's four-strain (quadrivalent) influenza vaccine Vaxigrip has been accepted by the European Medicines Agency (EMA) for review for approval ... If approved, Vaxigrip will be
-
Sanofi has 65 new compounds in development, says R&D chief
hexavalent vaccine (DTP-Hep B-Polio-Hib), as well as a filing in the EU for Sanofi's quadrivalent flu vaccine Vaxigrip QIV.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Principal Medical Writer
-
Varies on experience
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- CureVac expands COVID-19 vaccine trial protocol to include variant specification
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Lucid Group Bolster its Senior Leadership Team
- Live Webinar: Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Opdivo improves survival in oesophageal cancer
- Keytruda shows significant and meaningfully improvement in kidney cancer
- Congress 2020 BC (before COVID-19)
- Shaping the Future of Medicine, Science, and Technology
- Live Webinar: Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
- How to tell your healthcare story.
- Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....
Quick links
Infographics
